Literature DB >> 34861413

GRB10 regulates β-cell mass by inhibiting β-cell proliferation and stimulating β-cell dedifferentiation.

Zixin Cai1, Fen Liu1, Yan Yang1, Dandan Li1, Shanbiao Hu2, Lei Song2, Shaojie Yu2, Ting Li3, Bilian Liu1, Hairong Luo1, Weiping Zhang4, Zhiguang Zhou1, Jingjing Zhang5.   

Abstract

Decreased functional β-cell mass is the hallmark of diabetes, but the cause of this metabolic defect remains elusive. Here, we show that the levels of the growth factor receptor-bound protein 10 (GRB10), a negative regulator of insulin and mTORC1 signaling, are markedly induced in islets of diabetic mice and high glucose-treated insulinoma cell line INS-1 cells. β-cell-specific knockout of Grb10 in mice increased β-cell mass and improved β-cell function. Grb10-deficient β-cells exhibit enhanced mTORC1 signaling and reduced β-cell dedifferentiation, which could be blocked by rapamycin. On the contrary, Grb10 overexpression induced β-cell dedifferentiation in MIN6 cells. Our study identifies GRB10 as a critical regulator of β-cell dedifferentiation and β-cell mass, which exerts its effect by inhibiting mTORC1 signaling.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Dedifferentiation; Grb10; mTORC1; β-cell mass

Mesh:

Substances:

Year:  2021        PMID: 34861413     DOI: 10.1016/j.jgg.2021.11.006

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   5.723


  1 in total

1.  GRB10 is a novel oncogene associated with cell proliferation and prognosis in glioma.

Authors:  Yuanbing Chen; Miao Tang; Jianbing Xiong; Qiongjue Gao; Wuyang Cao; Jun Huang
Journal:  Cancer Cell Int       Date:  2022-07-05       Impact factor: 6.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.